Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 352 (9123), 167-172
- https://doi.org/10.1016/s0140-6736(97)11509-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Relationships Between Changes in Body Composition and Changes in Cardiovascular Risk Factors: The SOS Intervention StudyObesity Research, 1997
- Diet Pills ReduxNew England Journal of Medicine, 1997
- Time Trends in Obesity: An Epidemiological PerspectiveHormone and Metabolic Research, 1997
- Long-term Pharmacotherapy in the Management of ObesityJAMA, 1996
- The Effect of Orlistat, an Inhibitor of Dietary Fat Absorption, on the Absorption of Vitamins A and E in Healthy VolunteersThe Journal of Clinical Pharmacology, 1996
- The Effect of Orlistat, an Inhibitor of Dietary Fat Absorption, on the Pharmacokinetics of β‐Carotene in Healthy VolunteersThe Journal of Clinical Pharmacology, 1996
- Increasing Prevalence of Overweight Among US AdultsJAMA, 1994
- The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemiaEuropean Journal of Clinical Pharmacology, 1994
- Trends in body mass index and prevalence of obesity in Swedish women 1980-89.Journal of Epidemiology and Community Health, 1993
- INTERNATIONAL TRIAL OF LONG-TERM DEXFENFLURAMINE IN OBESITYThe Lancet, 1989